Axinn Advised Columbia Care in its $240M Acquisition of Green Leaf Medical
May 3, 2021
Axinn represented Columbia Care, a market leader in the two largest cannabis markets in the world (California and Colorado) in its acquisition of Green Leaf Medical, a privately held, fully-integrated cannabis multi-state operator based in the mid-Atlantic region for $240 million with the potential for additional performance-based milestone payments. Announced on December 22, 2020, the acquisition of Green Leaf will expand Columbia Care’s operational scale and footprint in four key, limited license markets by materially enhancing the scale and capabilities of its seed-to-sale operations. The deal closed on June 11, 2021.
The Axinn team was led by Lisl Dunlop and assisted by associate Sam Sherman.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
GCR Live: Law Leaders Europe 2025
Speaking Engagement
Antitrust
AHLA Annual Meeting 2025
Speaking Engagement
Antitrust
SABA North America Annual Conference 2025
Speaking Engagement
Antitrust
Navigating Compliance: How the 2025 Hart-Scott-Rodino Updates Are Impacting Businesses
Webinar
Antitrust
NJSBA Annual Meeting and Convention 2025
Speaking Engagement
Intellectual Property
Cost-Effective and Efficient IP Litigation Strategies – Making Paragraph IV Litigation Work for You
Webinar
Intellectual Property
Hartford HealthCare Black and Red Gala 2025
Sponsorship
Antitrust
Informa CompLaw Antitrust West Coast Conference 2025
Speaking Engagement
Antitrust
AHLA Health Care Transactions Program 2025
Sponsorship
Antitrust
Five Healthcare Antitrust Topics to Watch at the Upcoming Health Care Transactions Conference in Nashville
Axinn Viewpoints
Antitrust